RIVKAH COLEN

TitleAssistant Professor
InstitutionMD Anderson
DepartmentCancer Systems Imaging
Address1400 Pressler St
Houston TX 77030-4008
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Gongala S, Garcia JA, Korakavi N, Patil N, Akbari H, Sloan A, Barnholtz-Sloan JS, Sun J, Griffith B, Poisson LM, Booth TC, Jain R, Mohan S, Nasralla MP, Bakas S, Tippareddy C, Puig J, Palmer JD, Shi W, Colen RR, Sotiras A, Ahn SS, Park YW, Davatzikos C, Badve C. Sex-specific Differences in IDH1-Wildtype Glioblastoma patients in the ReSPOND Consortium. AJNR Am J Neuroradiol. 2024 Apr 29. PMID: 38684319.
      Citations:    Fields:    
    2. Tompkins A, Gray ZN, Dadey RE, Zenkin S, Batavani N, Newman S, Amouzegar A, Ak M, Ak N, Pak TY, Peddagangireddy V, Mamindla P, Behr S, Goodman A, Ploucha DL, Kirkwood JM, Zarour HM, Najjar YG, Davar D, Colen R, Luke JJ, Bao R. Radiomic analysis of patient and inter-organ heterogeneity in response to immunotherapies and BRAF targeted therapy in metastatic melanoma. medRxiv. 2024 Apr 27. PMID: 38712112; PMCID: PMC11071587.
      Citations:    
    3. de Miguel-Perez D, Ak M, Mamindla P, Russo A, Zenkin S, Ak N, Peddagangireddy V, Lara-Mejia L, Gunasekaran M, Cardona AF, Naing A, Hirsch FR, Arrieta O, Colen RR, Rolfo C. Validation of a multiomic model of plasma extracellular vesicle PD-L1 and radiomics for prediction of response to immunotherapy in NSCLC. J Exp Clin Cancer Res. 2024 Mar 15; 43(1):81. PMID: 38486328; PMCID: PMC10941547.
      Citations:    Fields:    Translation:HumansCells
    4. Alan N, Zenkin S, Lavadi RS, Legarreta AD, Hudson JS, Agarwal N, Mamindla P, Ak M, Peddagangireddy V, Puccio L, Buell TJ, Hamilton DK, Kanter AS, Okonkwo DO, Zinn PO, Colen RR, Fields DP. Associating T1-Weighted and T2-Weighted Magnetic Resonance Imaging Radiomic Signatures With Preoperative Symptom Severity in Patients With Cervical Spondylotic Myelopathy. World Neurosurg. 2024 04; 184:e137-e143. PMID: 38253177.
      Citations:    Fields:    
    5. Singh SK, Wang Y, Habib A, Priyadarshini M, Kodavali CV, Chen A, Ma W, Wang J, Hameed NUF, Hu B, Fuller GN, Kulich SM, Amankulor N, Colen RR, Edwards LA, Zinn PO. TP53-PTEN-NF1 depletion in human brain organoids produces a glioma phenotype in vitro. Front Oncol. 2023; 13:1279806. PMID: 37881491; PMCID: PMC10597663.
      Citations:    
    6. Lee MD, Patel SH, Mohan S, Akbari H, Bakas S, Nasrallah MP, Calabrese E, Rudie J, Villanueva-Meyer J, LaMontagne P, Marcus DS, Colen RR, Balana C, Choi YS, Badve C, Barnholtz-Sloan JS, Sloan AE, Booth TC, Palmer JD, Dicker AP, Flanders AE, Shi W, Griffith B, Poisson LM, Chakravarti A, Mahajan A, Chang S, Orringer D, Davatzikos C, Jain R, ReSPOND Consortium. Association of partial T2-FLAIR mismatch sign and isocitrate dehydrogenase mutation in WHO grade 4 gliomas: results from the ReSPOND consortium. Neuroradiology. 2023 Sep; 65(9):1343-1352. PMID: 37468750; PMCID: PMC11058040.
      Citations: 2     Fields:    Translation:Humans
    7. Hasanov M, Milton DR, Davies AB, Sirmans E, Saberian C, Posada EL, Opusunju S, Gershenwald JE, Torres-Cabala CA, Burton EM, Colen RR, Huse JT, Glitza Oliva IC, Chung C, McAleer MF, McGovern SL, Yeboa DN, Kim BYS, Prabhu SS, McCutcheon IE, Weinberg JS, Lang FF, Tawbi HA, Li J, Haydu LE, Davies MA, Ferguson SD. Changes in outcomes and factors associated with survival in melanoma patients with brain metastases. Neuro Oncol. 2023 Jul 06; 25(7):1310-1320. PMID: 36510640; PMCID: PMC10326492.
      Citations: 1     Fields:    Translation:Humans
    8. Faro SH, Manmatharayan A, Leiby B, Jain N, Mohamed FB, Talekar KS, Doshi A, Jambor I, Chang S, Finkelstein M, Kremer S, Lersy F, Lindgren B, Figueiredo NM, Gerevini S, Napolitano A, Jain R, Dogra S, Pillai JJ, Ryan D, Jager R, Carletti F, Mian A, Kaliev A, Anand P, Takahashi C, Murat A, Colen R, Mansueto G, Pizzini F. Neuroimaging findings in 4342 hospitalized COVID-19 subjects: A multicenter report from the United States and Europe. J Neuroimaging. 2023 Sep-Oct; 33(5):752-763. PMID: 37381160.
      Citations: 1     Fields:    Translation:Humans
    9. Li HB, Conte GM, Anwar SM, Kofler F, Ezhov I, van Leemput K, Piraud M, Diaz M, Cole B, Calabrese E, Rudie J, Meissen F, Adewole M, Janas A, Kazerooni AF, LaBella D, Moawad AW, Farahani K, Eddy J, Bergquist T, Chung V, Shinohara RT, Dako F, Wiggins W, Reitman Z, Wang C, Liu X, Jiang Z, Familiar A, Johanson E, Meier Z, Davatzikos C, Freymann J, Kirby J, Bilello M, Fathallah-Shaykh HM, Wiest R, Kirschke J, Colen RR, Kotrotsou A, Lamontagne P, Marcus D, Milchenko M, Nazeri A, Weber MA, Mahajan A, Mohan S, Mongan J, Hess C, Cha S, Villanueva-Meyer J, Colak E, Crivellaro P, Jakab A, Albrecht J, Anazodo U, Aboian M, Yu T, Baid U, Bakas S, Linguraru MG, Menze B, Iglesias JE, Wiestler B. The Brain Tumor Segmentation (BraTS) Challenge 2023: Brain MR Image Synthesis for Tumor Segmentation (BraSyn). ArXiv. 2023 Jun 28. PMID: 37608932; PMCID: PMC10441440.
      Citations:    
    10. Pati S, Baid U, Edwards B, Sheller M, Wang SH, Reina GA, Foley P, Gruzdev A, Karkada D, Davatzikos C, Sako C, Ghodasara S, Bilello M, Mohan S, Vollmuth P, Brugnara G, Preetha CJ, Sahm F, Maier-Hein K, Zenk M, Bendszus M, Wick W, Calabrese E, Rudie J, Villanueva-Meyer J, Cha S, Ingalhalikar M, Jadhav M, Pandey U, Saini J, Garrett J, Larson M, Jeraj R, Currie S, Frood R, Fatania K, Huang RY, Chang K, Bala?a C, Capellades J, Puig J, Trenkler J, Pichler J, Necker G, Haunschmidt A, Meckel S, Shukla G, Liem S, Alexander GS, Lombardo J, Palmer JD, Flanders AE, Dicker AP, Sair HI, Jones CK, Venkataraman A, Jiang M, So TY, Chen C, Heng PA, Dou Q, Kozubek M, Lux F, Mich?lek J, Matula P, Kerkovsk? M, Koprivov? T, Dost?l M, Vyb?hal V, Vogelbaum MA, Mitchell JR, Farinhas J, Maldjian JA, Yogananda CGB, Pinho MC, Reddy D, Holcomb J, Wagner BC, Ellingson BM, Cloughesy TF, Raymond C, Oughourlian T, Hagiwara A, Wang C, To MS, Bhardwaj S, Chong C, Agzarian M, Falc?o AX, Martins SB, Teixeira BCA, Sprenger F, Menotti D, Lucio DR, LaMontagne P, Marcus D, Wiestler B, Kofler F, Ezhov I, Metz M, Jain R, Lee M, Lui YW, McKinley R, Slotboom J, Radojewski P, Meier R, Wiest R, Murcia D, Fu E, Haas R, Thompson J, Ormond DR, Badve C, Sloan AE, Vadmal V, Waite K, Colen RR, Pei L, Ak M, Srinivasan A, Bapuraj JR, Rao A, Wang N, Yoshiaki O, Moritani T, Turk S, Lee J, Prabhudesai S, Mor?n F, Mandel J, Kamnitsas K, Glocker B, Dixon LVM, Williams M, Zampakis P, Panagiotopoulos V, Tsiganos P, Alexiou S, Haliassos I, Zacharaki EI, Moustakas K, Kalogeropoulou C, Kardamakis DM, Choi YS, Lee SK, Chang JH, Ahn SS, Luo B, Poisson L, Wen N, Tiwari P, Verma R, Bareja R, Yadav I, Chen J, Kumar N, Smits M, van der Voort SR, Alafandi A, Incekara F, Wijnenga MMJ, Kapsas G, Gahrmann R, Schouten JW, Dubbink HJ, Vincent AJPE, van den Bent MJ, French PJ, Klein S, Yuan Y, Sharma S, Tseng TC, Adabi S, Niclou SP, Keunen O, Hau AC, Valli?res M, Fortin D, Lepage M, Landman B, Ramadass K, Xu K, Chotai S, Chambless LB, Mistry A, Thompson RC, Gusev Y, Bhuvaneshwar K, Sayah A, Bencheqroun C, Belouali A, Madhavan S, Booth TC, Chelliah A, Modat M, Shuaib H, Dragos C, Abayazeed A, Kolodziej K, Hill M, Abbassy A, Gamal S, Mekhaimar M, Qayati M, Reyes M, Park JE, Yun J, Kim HS, Mahajan A, Muzi M, Benson S, Beets-Tan RGH, Teuwen J, Herrera-Trujillo A, Trujillo M, Escobar W, Abello A, Bernal J, G?mez J, Choi J, Baek S, Kim Y, Ismael H, Allen B, Buatti JM, Kotrotsou A, Li H, Weiss T, Weller M, Bink A, Pouymayou B, Shaykh HF, Saltz J, Prasanna P, Shrestha S, Mani KM, Payne D, Kurc T, Pelaez E, Franco-Maldonado H, Loayza F, Quevedo S, Guevara P, Torche E, Mendoza C, Vera F, R?os E, L?pez E, Velastin SA, Ogbole G, Soneye M, Oyekunle D, Odafe-Oyibotha O, Osobu B, Shu'aibu M, Dorcas A, Dako F, Simpson AL, Hamghalam M, Peoples JJ, Hu R, Tran A, Cutler D, Moraes FY, Boss MA, Gimpel J, Veettil DK, Schmidt K, Bialecki B, Marella S, Price C, Cimino L, Apgar C, Shah P, Menze B, Barnholtz-Sloan JS, Martin J, Bakas S. Author Correction: Federated learning enables big data for rare cancer boundary detection. Nat Commun. 2023 Jan 26; 14(1):436. PMID: 36702828; PMCID: PMC9879935.
      Citations:    Fields:    
    11. Pati S, Baid U, Edwards B, Sheller M, Wang SH, Reina GA, Foley P, Gruzdev A, Karkada D, Davatzikos C, Sako C, Ghodasara S, Bilello M, Mohan S, Vollmuth P, Brugnara G, Preetha CJ, Sahm F, Maier-Hein K, Zenk M, Bendszus M, Wick W, Calabrese E, Rudie J, Villanueva-Meyer J, Cha S, Ingalhalikar M, Jadhav M, Pandey U, Saini J, Garrett J, Larson M, Jeraj R, Currie S, Frood R, Fatania K, Huang RY, Chang K, Bala?a C, Capellades J, Puig J, Trenkler J, Pichler J, Necker G, Haunschmidt A, Meckel S, Shukla G, Liem S, Alexander GS, Lombardo J, Palmer JD, Flanders AE, Dicker AP, Sair HI, Jones CK, Venkataraman A, Jiang M, So TY, Chen C, Heng PA, Dou Q, Kozubek M, Lux F, Mich?lek J, Matula P, Kerkovsk? M, Koprivov? T, Dost?l M, Vyb?hal V, Vogelbaum MA, Mitchell JR, Farinhas J, Maldjian JA, Yogananda CGB, Pinho MC, Reddy D, Holcomb J, Wagner BC, Ellingson BM, Cloughesy TF, Raymond C, Oughourlian T, Hagiwara A, Wang C, To MS, Bhardwaj S, Chong C, Agzarian M, Falc?o AX, Martins SB, Teixeira BCA, Sprenger F, Menotti D, Lucio DR, LaMontagne P, Marcus D, Wiestler B, Kofler F, Ezhov I, Metz M, Jain R, Lee M, Lui YW, McKinley R, Slotboom J, Radojewski P, Meier R, Wiest R, Murcia D, Fu E, Haas R, Thompson J, Ormond DR, Badve C, Sloan AE, Vadmal V, Waite K, Colen RR, Pei L, Ak M, Srinivasan A, Bapuraj JR, Rao A, Wang N, Yoshiaki O, Moritani T, Turk S, Lee J, Prabhudesai S, Mor?n F, Mandel J, Kamnitsas K, Glocker B, Dixon LVM, Williams M, Zampakis P, Panagiotopoulos V, Tsiganos P, Alexiou S, Haliassos I, Zacharaki EI, Moustakas K, Kalogeropoulou C, Kardamakis DM, Choi YS, Lee SK, Chang JH, Ahn SS, Luo B, Poisson L, Wen N, Tiwari P, Verma R, Bareja R, Yadav I, Chen J, Kumar N, Smits M, van der Voort SR, Alafandi A, Incekara F, Wijnenga MMJ, Kapsas G, Gahrmann R, Schouten JW, Dubbink HJ, Vincent AJPE, van den Bent MJ, French PJ, Klein S, Yuan Y, Sharma S, Tseng TC, Adabi S, Niclou SP, Keunen O, Hau AC, Valli?res M, Fortin D, Lepage M, Landman B, Ramadass K, Xu K, Chotai S, Chambless LB, Mistry A, Thompson RC, Gusev Y, Bhuvaneshwar K, Sayah A, Bencheqroun C, Belouali A, Madhavan S, Booth TC, Chelliah A, Modat M, Shuaib H, Dragos C, Abayazeed A, Kolodziej K, Hill M, Abbassy A, Gamal S, Mekhaimar M, Qayati M, Reyes M, Park JE, Yun J, Kim HS, Mahajan A, Muzi M, Benson S, Beets-Tan RGH, Teuwen J, Herrera-Trujillo A, Trujillo M, Escobar W, Abello A, Bernal J, G?mez J, Choi J, Baek S, Kim Y, Ismael H, Allen B, Buatti JM, Kotrotsou A, Li H, Weiss T, Weller M, Bink A, Pouymayou B, Shaykh HF, Saltz J, Prasanna P, Shrestha S, Mani KM, Payne D, Kurc T, Pelaez E, Franco-Maldonado H, Loayza F, Quevedo S, Guevara P, Torche E, Mendoza C, Vera F, R?os E, L?pez E, Velastin SA, Ogbole G, Soneye M, Oyekunle D, Odafe-Oyibotha O, Osobu B, Shu'aibu M, Dorcas A, Dako F, Simpson AL, Hamghalam M, Peoples JJ, Hu R, Tran A, Cutler D, Moraes FY, Boss MA, Gimpel J, Veettil DK, Schmidt K, Bialecki B, Marella S, Price C, Cimino L, Apgar C, Shah P, Menze B, Barnholtz-Sloan JS, Martin J, Bakas S. Federated learning enables big data for rare cancer boundary detection. Nat Commun. 2022 12 05; 13(1):7346. PMID: 36470898; PMCID: PMC9722782.
      Citations: 15     Fields:    Translation:Humans
    12. Mehta R, Filos A, Baid U, Sako C, McKinley R, Rebsamen M, D?twyler K, Meier R, Radojewski P, Murugesan GK, Nalawade S, Ganesh C, Wagner B, Yu FF, Fei B, Madhuranthakam AJ, Maldjian JA, Daza L, G?mez C, Arbel?ez P, Dai C, Wang S, Reynaud H, Mo Y, Angelini E, Guo Y, Bai W, Banerjee S, Pei L, Ak M, Rosas-Gonz?lez S, Zemmoura I, Tauber C, Vu MH, Nyholm T, L?fstedt T, Ballestar LM, Vilaplana V, McHugh H, Maso Talou G, Wang A, Patel J, Chang K, Hoebel K, Gidwani M, Arun N, Gupta S, Aggarwal M, Singh P, Gerstner ER, Kalpathy-Cramer J, Boutry N, Huard A, Vidyaratne L, Rahman MM, Iftekharuddin KM, Chazalon J, Puybareau E, Tochon G, Ma J, Cabezas M, Llado X, Oliver A, Valencia L, Valverde S, Amian M, Soltaninejad M, Myronenko A, Hatamizadeh A, Feng X, Dou Q, Tustison N, Meyer C, Shah NA, Talbar S, Weber MA, Mahajan A, Jakab A, Wiest R, Fathallah-Shaykh HM, Nazeri A, Milchenko M, Marcus D, Kotrotsou A, Colen R, Freymann J, Kirby J, Davatzikos C, Menze B, Bakas S, Gal Y, Arbel T. QU-BraTS: MICCAI BraTS 2020 Challenge on Quantifying Uncertainty in Brain Tumor Segmentation - Analysis of Ranking Scores and Benchmarking Results. J Mach Learn Biomed Imaging. 2022 Aug; 2022. PMID: 36998700; PMCID: PMC10060060.
      Citations: 4     
    13. Pei L, Ak M, Tahon NHM, Zenkin S, Alkarawi S, Kamal A, Yilmaz M, Chen L, Er M, Ak N, Colen R. Author Correction: A general skull stripping of multiparametric brain MRIs using 3D convolutional neural network. Sci Rep. 2022 Jul 25; 12(1):12664. PMID: 35879397; PMCID: PMC9314390.
      Citations:    Fields:    
    14. Pei L, Ak M, Tahon NHM, Zenkin S, Alkarawi S, Kamal A, Yilmaz M, Chen L, Er M, Ak N, Colen R. A general skull stripping of multiparametric brain MRIs using 3D convolutional neural network. Sci Rep. 2022 06 27; 12(1):10826. PMID: 35760886; PMCID: PMC9237075.
      Citations:    Fields:    Translation:Humans
    15. de Miguel-Perez D, Russo A, Ak M, Gunasekaran M, Mamindla P, Peterson CB, Er ME, Peddagangireddy V, Buemi F, Cooper B, Manca P, Lapidus RG, Hsia RC, Naing A, Kaushal S, Hirsch FR, Mack PC, Serrano MJ, Adamo V, Colen RR, Rolfo C, Arrieta O, Barron F, Lara-Mejia L, Cardona AF. Extracellular vesicle PD-L1 dynamics predict durable response to immune-checkpoint inhibitors and survival in patients with?non-small cell lung cancer. J Exp Clin Cancer Res. 2022 Jun 02; 41(1):186. PMID: 35650597; PMCID: PMC9161571.
      Citations:    Fields:    Translation:HumansCells
    16. Hsu WW, Guo JM, Pei L, Chiang LA, Li YF, Hsiao JC, Colen R, Liu P. A weakly supervised deep learning-based method for glioma subtype classification using WSI and mpMRIs. Sci Rep. 2022 04 12; 12(1):6111. PMID: 35414643; PMCID: PMC9005548.
      Citations:    Fields:    Translation:Humans
    17. Thein KZ, Piha-Paul SA, Tsimberidou A, Karp DD, Janku F, Zarifa A, Shah J, Bean S, McQuinn L, Gong J, Colen R, Carter BW, Subbiah V, Ogbonna DC, Pant S, Meric-Bernstam F, Naing A, Milton DR. Correction to: Selinexor in combination with topotecan in patients with advanced or metastatic solid tumors: Results of an open-label, single-center, multi-arm phase Ib study. Invest New Drugs. 2022 Apr; 40(2):461. PMID: 34705134; PMCID: PMC8993725.
      Citations:    Fields:    
    18. Thein KZ, Karp DD, Tsimberidou A, Gong J, Sulovic S, Shah J, Hong DS, Janku F, McQuinn L, Stephen BA, Colen R, Carter BW, Yap TA, Piha-Paul SA, Fu S, Meric-Bernstam F, Naing A, Milton DR. Correction to: Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: results of a single-center, multi-arm phase Ib study. Invest New Drugs. 2022 Apr; 40(2):463. PMID: 34731355; PMCID: PMC8993707.
      Citations:    Fields:    
    19. Thein KZ, Fu S, Janku F, Tsimberidou AM, Piha-Paul SA, Karp DD, Shah J, Gong J, Sulovic S, McQuinn L, Stephen BA, Colen RR, Carter BW, Meric-Bernstam F, Naing A, Milton DR. Selinexor in Combination with Carboplatin and Pemetrexed in Patients with Advanced or Metastatic Solid Tumors: Results of an Open-Label, Single-Center, Multi-Arm Phase 1b Study. J Immunother Precis Oncol. 2022 Feb; 5(1):10-12. PMID: 35663832; PMCID: PMC9138422.
      Citations:    
    20. Thein KZ, Piha-Paul SA, Tsimberidou A, Karp DD, Janku F, Fu S, Subbiah V, Hong DS, Yap TA, Shah J, McQuinn L, Gong J, Tran Y, Carter BW, Colen R, Meric-Bernstam F, Naing A, Milton DR. Selinexor in combination with standard chemotherapy in patients with advanced or metastatic solid tumors. Exp Hematol Oncol. 2021 Dec 29; 10(1):59. PMID: 34965890; PMCID: PMC8715578.
      Citations:    
    21. Thein KZ, Karp DD, Tsimberidou A, Gong J, Sulovic S, Shah J, Hong DS, Janku F, McQuinn L, Stephen BA, Colen R, Carter BW, Yap TA, Piha-Paul SA, Fu S, Meric-Bernstam F, Naing A, Milton DR. Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: Results of a single-center, multi-arm phase Ib study. Invest New Drugs. 2022 04; 40(2):290-299. PMID: 34562230; PMCID: PMC8993773.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    22. Foster A, Nigam S, Tatum DS, Raphael I, Xu J, Kumar R, Plakseychuk E, Latoche JD, Vincze S, Li B, Giri R, McCarl LH, Edinger R, Ak M, Peddagangireddy V, Foley LM, Hitchens TK, Colen RR, Pollack IF, Panigrahy A, Magda D, Anderson CJ, Edwards WB, Kohanbash G. Novel theranostic agent for PET imaging and targeted radiopharmaceutical therapy of tumour-infiltrating immune cells in glioma. EBioMedicine. 2021 Sep; 71:103571. PMID: 34530385; PMCID: PMC8446777.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    23. Tran HT, Lam VK, Elamin YY, Hong L, Colen R, Elshafeey NA, Hassan ISA, Altan M, Blumenschein GR, Rinsurongkawong W, Rivera MJ, Vasquez ME, Carter BW, Byers LE, Tsao AS, Gibbons DL, Fossella F, Glisson BS, Zhang J, Heymach JV. Clinical Outcomes in Non-Small-Cell Lung Cancer Patients Treated With EGFR-Tyrosine Kinase Inhibitors and Other Targeted Therapies Based on Tumor Versus Plasma Genomic Profiling. JCO Precis Oncol. 2021 08; 5. PMID: 34377884; PMCID: PMC8345916.
      Citations: 5     Fields:    Translation:Humans
    24. Colen RR, Rolfo C, Ak M, Ayoub M, Ahmed S, Elshafeey N, Mamindla P, Zinn PO, Ng C, Vikram R, Bakas S, Peterson CB, Rodon Ahnert J, Subbiah V, Karp DD, Stephen B, Hajjar J, Naing A. Author response to Cunha et al. J Immunother Cancer. 2021 07; 9(7). PMID: 34315823; PMCID: PMC8317086.
      Citations:    Fields:    Translation:Humans
    25. Xu M, Tapia C, Hajjar J, Sabir S, Colen R, Nagarajan P, Aung PP, Gong J, Rodon J, Fu S, Stephen B, Roy-Chowdhuri S, Le H, Yang V, Zarifa A, Abdelsalam ME, Jhingran A, Javle M, Pant S, Carter B, Milton DR, Sun R, Karp DD, Koay EJ, Yang Y, Wistuba II, Hwu P, Meric-Bernstam F, Naing A. Implementation of a Novel Web-Based Lesion Selection Tool to Improve Acquisition of Tumor Biopsy Specimens. J Immunother Precis Oncol. 2021 May; 4(2):45-52. PMID: 35663531; PMCID: PMC9153261.
      Citations: 3     
    26. Thein KZ, Piha-Paul SA, Tsimberidou A, Karp DD, Janku F, Zarifa A, Shah J, Bean S, McQuinn L, Gong J, Colen R, Carter BW, Subbiah V, Ogbonna DC, Pant S, Meric-Bernstam F, Naing A, Milton DR. Selinexor in combination with topotecan in patients with advanced or metastatic solid tumors: Results of an open-label, single-center, multi-arm phase Ib study. Invest New Drugs. 2021 10; 39(5):1357-1365. PMID: 33909232; PMCID: PMC8542012.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    27. Colen RR, Rolfo C, Ak M, Ayoub M, Ahmed S, Elshafeey N, Mamindla P, Zinn PO, Ng C, Vikram R, Bakas S, Peterson CB, Rodon Ahnert J, Subbiah V, Karp DD, Stephen B, Hajjar J, Naing A. Radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancers. J Immunother Cancer. 2021 04; 9(4). PMID: 33849924; PMCID: PMC8051405.
      Citations: 9     Fields:    Translation:Humans
    28. Chen BT, Jin T, Ye N, Mambetsariev I, Wang T, Wong CW, Chen Z, Rockne RC, Colen RR, Holodny AI, Sampath S, Salgia R. Predicting Survival Duration With MRI Radiomics of Brain Metastases From Non-small Cell Lung Cancer. Front Oncol. 2021; 11:621088. PMID: 33747933; PMCID: PMC7973105.
      Citations: 5     
    29. Ak M, Eleneen Y, Ayoub M, Colen RR. Cancer Imaging in Immunotherapy. Adv Exp Med Biol. 2021; 1342:431-447. PMID: 34972979.
      Citations:    Fields:    Translation:Humans
    30. Khan B, Chong I, Ostrom Q, Ahmed S, Dandachi D, Kotrotsou A, Colen R, Mor?n F. Diffusion-weighted MR imaging histogram analysis in HIV positive and negative patients with primary central nervous system lymphoma as a predictor of outcome and tumor proliferation. Oncotarget. 2020 Nov 10; 11(45):4093-4103. PMID: 33227089; PMCID: PMC7665236.
      Citations:    Fields:    
    31. Ferguson SD, Hodges TR, Majd NK, Alfaro-Munoz K, Al-Holou WN, Suki D, de Groot JF, Fuller GN, Xue L, Li M, Jacobs C, Rao G, Colen RR, Xiu J, Verhaak R, Spetzler D, Khasraw M, Sawaya R, Long JP, Heimberger AB. A validated integrated clinical and molecular glioblastoma long-term survival-predictive nomogram. Neurooncol Adv. 2021 Jan-Dec; 3(1):vdaa146. PMID: 33426529; PMCID: PMC7780842.
      Citations: 1     
    32. Khatua S, Cooper LJN, Sandberg DI, Ketonen L, Johnson JM, Rytting ME, Liu DD, Meador H, Trikha P, Nakkula RJ, Behbehani GK, Ragoonanan D, Gupta S, Kotrotsou A, Idris T, Shpall EJ, Rezvani K, Colen R, Zaky W, Lee DA, Gopalakrishnan V. Phase I study of intraventricular infusions of autologous ex vivo expanded NK cells in children with recurrent medulloblastoma and ependymoma. Neuro Oncol. 2020 08 17; 22(8):1214-1225. PMID: 32152626; PMCID: PMC7594549.
      Citations: 15     Fields:    Translation:HumansCellsCTClinical Trials
    33. Sheller MJ, Edwards B, Reina GA, Martin J, Pati S, Kotrotsou A, Milchenko M, Xu W, Marcus D, Colen RR, Bakas S. Federated learning in medicine: facilitating multi-institutional collaborations without sharing patient data. Sci Rep. 2020 07 28; 10(1):12598. PMID: 32724046; PMCID: PMC7387485.
      Citations: 55     Fields:    Translation:Humans
    34. Kumar VA, Heiba IM, Prabhu SS, Chen MM, Colen RR, Young AL, Johnson JM, Hou P, Noll K, Ferguson SD, Rao G, Lang FF, Schomer DF, Liu HL. The role of resting-state functional MRI for clinical preoperative language mapping. Cancer Imaging. 2020 Jul 11; 20(1):47. PMID: 32653026; PMCID: PMC7353792.
      Citations: 1     Fields:    Translation:Humans
    35. Thakur S, Doshi J, Pati S, Rathore S, Sako C, Bilello M, Ha SM, Shukla G, Flanders A, Kotrotsou A, Milchenko M, Liem S, Alexander GS, Lombardo J, Palmer JD, LaMontagne P, Nazeri A, Talbar S, Kulkarni U, Marcus D, Colen R, Davatzikos C, Erus G, Bakas S. Brain extraction on MRI scans in presence of diffuse glioma: Multi-institutional performance evaluation of deep learning methods and robust modality-agnostic training. Neuroimage. 2020 10 15; 220:117081. PMID: 32603860; PMCID: PMC7597856.
      Citations: 10     Fields:    Translation:Humans
    36. Davatzikos C, Barnholtz-Sloan JS, Bakas S, Colen R, Mahajan A, Capellades Font J, Puig J, Jain R, Sloan AE, Badve C, Marcus DS, Seong Choi Y, Lee SK, Chang JH, Poisson LM, Griffith B, Dicker AP, Flanders AE, Booth TC, Rathore S, Akbari H, Sako C, Bilello M, Shukla G, Fathi Kazerooni A, Brem S, Lustig R, Mohan S, Bagley S, Nasrallah M, O'Rourke DM, Quintero CB. AI-based prognostic imaging biomarkers for precision neuro-oncology: the ReSPOND consortium. Neuro Oncol. 2020 06 09; 22(6):886-888. PMID: 32152622; PMCID: PMC7283022.
      Citations: 11     Fields:    Translation:Humans
    37. Vedantam A, Hassan I, Kotrotsou A, Hassan A, Zinn PO, Viswanathan A, Colen RR. Magnetic Resonance-Based Radiomic Analysis of Radiofrequency Lesion Predicts Outcomes After Percutaneous Cordotomy: A Feasibility Study. Oper Neurosurg (Hagerstown). 2020 06 01; 18(6):721-727. PMID: 31665446.
      Citations:    Fields:    Translation:Humans
    38. Chen BT, Chen Z, Ye N, Mambetsariev I, Fricke J, Daniel E, Wang G, Wong CW, Rockne RC, Colen RR, Nasser MW, Batra SK, Holodny AI, Sampath S, Salgia R. Differentiating Peripherally-Located Small Cell Lung Cancer From Non-small Cell Lung Cancer Using a CT Radiomic Approach. Front Oncol. 2020; 10:593. PMID: 32391274; PMCID: PMC7188953.
      Citations: 8     
    39. de Groot J, Penas-Prado M, Alfaro-Munoz K, Hunter K, Pei BL, O'Brien B, Weathers SP, Loghin M, Kamiya Matsouka C, Yung WKA, Mandel J, Wu J, Yuan Y, Zhou S, Fuller GN, Huse J, Rao G, Weinberg JS, Prabhu SS, McCutcheon IE, Lang FF, Ferguson SD, Sawaya R, Colen R, Yadav SS, Blando J, Vence L, Allison J, Sharma P, Heimberger AB. Window-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophages. Neuro Oncol. 2020 04 15; 22(4):539-549. PMID: 31755915; PMCID: PMC7158647.
      Citations: 41     Fields:    Translation:HumansCells
    40. Chen BT, Jin T, Ye N, Mambetsariev I, Daniel E, Wang T, Wong CW, Rockne RC, Colen R, Holodny AI, Sampath S, Salgia R. Radiomic prediction of mutation status based on MR imaging of lung cancer brain metastases. Magn Reson Imaging. 2020 06; 69:49-56. PMID: 32179095; PMCID: PMC7237274.
      Citations: 9     Fields:    Translation:Humans
    41. Naing A, Meric-Bernstam F, Stephen B, Karp DD, Hajjar J, Rodon Ahnert J, Piha-Paul SA, Colen RR, Jimenez C, Raghav KP, Ferrarotto R, Tu SM, Campbell M, Wang L, Sabir SH, Tapia C, Bernatchez C, Frumovitz M, Tannir N, Ravi V, Khan S, Painter JM, Abonofal A, Gong J, Alshawa A, McQuinn LM, Xu M, Ahmed S, Subbiah V, Hong DS, Pant S, Yap TA, Tsimberidou AM, Dumbrava EEI, Janku F, Fu S, Simon RM, Hess KR, Varadhachary GR, Habra MA. Phase 2 study of pembrolizumab in patients with advanced rare cancers. J Immunother Cancer. 2020 03; 8(1). PMID: 32188704; PMCID: PMC7078933.
      Citations: 32     Fields:    Translation:HumansCTClinical Trials
    42. Ayoub M, Eleneen Y, Colen RR. Cancer Imaging in Immunotherapy. Adv Exp Med Biol. 2020; 1244:309-324. PMID: 32301025.
      Citations:    Fields:    Translation:Humans
    43. Salem U, Kumar VA, Madewell JE, Schomer DF, de Almeida Bastos DC, Zinn PO, Weinberg JS, Rao G, Prabhu SS, Colen RR. Neurosurgical applications of MRI guided laser interstitial thermal therapy (LITT). Cancer Imaging. 2019 Oct 15; 19(1):65. PMID: 31615562; PMCID: PMC6792239.
      Citations: 16     Fields:    Translation:Humans
    44. Chong I, Ostrom Q, Khan B, Dandachi D, Garg N, Kotrotsou A, Colen R, Mor?n F. Whole Tumor Histogram Analysis Using DW MRI in Primary Central Nervous System Lymphoma Correlates with Tumor Biomarkers and Outcome. Cancers (Basel). 2019 Oct 08; 11(10). PMID: 31597366; PMCID: PMC6827036.
      Citations: 1     
    45. Elshafeey N, Kotrotsou A, Hassan A, Elshafei N, Hassan I, Ahmed S, Abrol S, Agarwal A, El Salek K, Bergamaschi S, Acharya J, Moron FE, Law M, Fuller GN, Huse JT, Zinn PO, Colen RR. Multicenter study demonstrates radiomic features derived from magnetic resonance perfusion images identify pseudoprogression in glioblastoma. Nat Commun. 2019 07 18; 10(1):3170. PMID: 31320621; PMCID: PMC6639324.
      Citations: 44     Fields:    Translation:Humans
    46. Dandachi D, Ostrom QT, Chong I, Serpa JA, Giordano TP, Kruchko C, Barnholtz-Sloan JS, Fowler N, Colen RR, Mor?n FE. Primary central nervous system lymphoma in patients with and without HIV infection: a multicenter study and comparison with U.S national data. Cancer Causes Control. 2019 May; 30(5):477-488. PMID: 30888569.
      Citations: 6     Fields:    Translation:Humans
    47. Luedi MM, Singh SK, Mosley JC, Hassan ISA, Hatami M, Gumin J, Andereggen L, Sulman EP, Lang FF, Stueber F, Fuller GN, Colen RR, Zinn PO. Dexamethasone-mediated oncogenicity in vitro and in an animal model of glioblastoma. J Neurosurg. 2018 12 01; 129(6):1446-1455. PMID: 29328002.
      Citations: 14     Fields:    Translation:HumansAnimalsCells
    48. Ellingson BM, Abrey LE, Nelson SJ, Kaufmann TJ, Garcia J, Chinot O, Saran F, Nishikawa R, Mason WP, Wick W, Butowski N, Ligon KL, Gerstner ER, Colman H, de Groot J, Chang S, Mellinghoff I, Young RJ, Alexander BM, Colen R, Taylor JW, Arrillaga-Romany I, Mehta A, Huang RY, Pope WB, Reardon D, Batchelor T, Prados M, Galanis E, Wen PY, Cloughesy TF, Henriksson R. Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma. Neuro Oncol. 2018 08 02; 20(9):1240-1250. PMID: 29660006; PMCID: PMC6071654.
      Citations: 27     Fields:    Translation:HumansCTClinical Trials
    49. Ng SP, Dyer BA, Kalpathy-Cramer J, Mohamed ASR, Awan MJ, Gunn GB, Phan J, Zafereo M, Debnam JM, Lewis CM, Colen RR, Kupferman ME, Guha-Thakurta N, Canahuate G, Marai GE, Vock D, Hamilton B, Holland J, Cardenas CE, Lai S, Rosenthal D, Fuller CD. A prospective in silico analysis of interdisciplinary and interobserver spatial variability in post-operative target delineation of high-risk oral cavity cancers: Does physician specialty matter? Clin Transl Radiat Oncol. 2018 Aug; 12:40-46. PMID: 30148217; PMCID: PMC6105928.
      Citations: 5     
    50. Zinn PO, Singh SK, Kotrotsou A, Hassan I, Thomas G, Luedi MM, Elakkad A, Elshafeey N, Idris T, Mosley J, Gumin J, Fuller GN, de Groot JF, Baladandayuthapani V, Sulman EP, Kumar AJ, Sawaya R, Lang FF, Piwnica-Worms D, Colen RR. A Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft Models. Clin Cancer Res. 2018 12 15; 24(24):6288-6299. PMID: 30054278; PMCID: PMC6538261.
      Citations: 37     Fields:    Translation:HumansAnimals
    51. Jen ML, Hassan I, Hou P, Li G, Kumar AJ, Prabhu SS, Colen RR, Liu HL. Comparison of functional localization accuracy with different co-registration strategies in presurgical fMRI for brain tumor patients. Med Phys. 2018 Jul; 45(7):3223-3228. PMID: 29799635.
      Citations:    Fields:    Translation:Humans
    52. Wintermark M, Colen R, Whitlow CT, Zaharchuk G. The vast potential and bright future of neuroimaging. Br J Radiol. 2018 Jul; 91(1087):20170505. PMID: 29848016; PMCID: PMC6221760.
      Citations: 2     Fields:    Translation:Humans
    53. Kotrotsou A, Elakkad A, Sun J, Thomas GA, Yang D, Abrol S, Wei W, Weinberg JS, Bakhtiari AS, Kircher MF, Luedi MM, de Groot JF, Sawaya R, Kumar AJ, Zinn PO, Colen RR. Multi-center study finds postoperative residual non-enhancing component of glioblastoma as a new determinant of patient outcome. J Neurooncol. 2018 Aug; 139(1):125-133. PMID: 29619649.
      Citations: 9     Fields:    Translation:Humans
    54. Fujii T, Colen RR, Bilen MA, Hess KR, Hajjar J, Suarez-Almazor ME, Alshawa A, Hong DS, Tsimberidou A, Janku F, Gong J, Stephen B, Subbiah V, Piha-Paul SA, Fu S, Sharma P, Mendoza T, Patel A, Thirumurthi S, Sheshadri A, Meric-Bernstam F, Naing A. Incidence of immune-related adverse events and its association with treatment outcomes: the MD Anderson Cancer Center experience. Invest New Drugs. 2018 08; 36(4):638-646. PMID: 29159766; PMCID: PMC5962379.
      Citations: 58     Fields:    Translation:Humans
    55. Colen RR, Fujii T, Bilen MA, Kotrotsou A, Abrol S, Hess KR, Hajjar J, Suarez-Almazor ME, Alshawa A, Hong DS, Giniebra-Camejo D, Stephen B, Subbiah V, Sheshadri A, Mendoza T, Fu S, Sharma P, Meric-Bernstam F, Naing A. Radiomics to predict immunotherapy-induced pneumonitis: proof of concept. Invest New Drugs. 2018 08; 36(4):601-607. PMID: 29075985; PMCID: PMC5924418.
      Citations: 40     Fields:    Translation:Humans
    56. Colen RR, Sahnoune I, Weinberg JS. Neurosurgical Applications of High-Intensity Focused Ultrasound with Magnetic Resonance Thermometry. Neurosurg Clin N Am. 2017 Oct; 28(4):559-567. PMID: 28917284.
      Citations: 3     Fields:    Translation:Humans
    57. Hatami M, Colen RR, Carlson BL, Decker PA, Sarkaria JN, Avril T, Etcheverry A, Pineau R, Obacz J, Jegou G, Jouan F, Le Reste PJ, Vaul?on E, Chiforeanu DC, Clavreul A, Mosser J, Chevet E, Quillien V. CD90 Expression Controls Migration and Predicts Dasatinib Response in Glioblastoma. Clin Cancer Res. 2017 Dec 01; 23(23):7360-7374. PMID: 28939749.
      Citations: 20     Fields:    Translation:HumansAnimalsCells
    58. Salek KE, Hassan IS, Kotrotsou A, Abrol S, Faro SH, Mohamed FB, Zinn PO, Wei W, Li N, Kumar AJ, Weinberg JS, Wefel JS, Kesler SR, Liu HA, Hou P, Stafford RJ, Prabhu S, Sawaya R, Colen RR. Silent Sentence Completion Shows Superiority Localizing Wernicke's Area and Activation Patterns of Distinct Language Paradigms Correlate with Genomics: Prospective Study. Sci Rep. 2017 09 21; 7(1):12054. PMID: 28935966; PMCID: PMC5608896.
      Citations: 4     Fields:    Translation:Humans
    59. Zinn PO, Singh SK, Kotrotsou A, Abrol S, Thomas G, Mosley J, Elakkad A, Hassan I, Kumar A, Colen RR. Distinct Radiomic Phenotypes Define Glioblastoma TP53-PTEN-EGFR Mutational Landscape. Neurosurgery. 2017 09 01; 64(CN_suppl_1):203-210. PMID: 28899058; PMCID: PMC6433436.
      Citations: 10     Fields:    
    60. Chaddad A, Luedi M, Zinn PO, Colen R. Corrigendum to "Automated Feature Extraction in Brain Tumor by Magnetic Resonance Imaging Using Gaussian Mixture Models". Int J Biomed Imaging. 2017; 2017:3247974. PMID: 28883830; PMCID: PMC5572088.
      Citations:    
    61. Huang C, Thompson P, Wang Y, Yu Y, Zhang J, Kong D, Colen RR, Knickmeyer RC, Zhu H, Alzheimer's Disease Neuroimaging Initiative. FGWAS: Functional genome wide association analysis. Neuroimage. 2017 10 01; 159:107-121. PMID: 28735012; PMCID: PMC5984052.
      Citations: 14     Fields:    Translation:Humans
    62. Cachia D, Elshafeey NA, Kamiya-Matsuoka C, Hatami M, Alfaro-Munoz KD, Mandel JJ, Colen R, DeGroot JF. Radiographic patterns of progression with associated outcomes after bevacizumab therapy in glioblastoma patients. J Neurooncol. 2017 Oct; 135(1):75-81. PMID: 28702781.
      Citations: 11     Fields:    Translation:Humans
    63. Ellingson BM, Gerstner ER, Smits M, Huang RY, Colen R, Abrey LE, Aftab DT, Schwab GM, Hessel C, Harris RJ, Chakhoyan A, Gahrmann R, Pope WB, Leu K, Raymond C, Woodworth DC, de Groot J, Wen PY, Batchelor TT, van den Bent MJ, Cloughesy TF. Diffusion MRI Phenotypes Predict Overall Survival Benefit from Anti-VEGF Monotherapy in Recurrent Glioblastoma: Converging Evidence from Phase II Trials. Clin Cancer Res. 2017 Oct 01; 23(19):5745-5756. PMID: 28655794; PMCID: PMC5626594.
      Citations: 24     Fields:    Translation:HumansCTClinical Trials
    64. Colen RR. Untying the Knot: What Lies Behind the Image? Top Magn Reson Imaging. 2017 Feb; 26(1):1. PMID: 28157828.
      Citations:    Fields:    Translation:Humans
    65. Kotrotsou A, Salem A, Zinn PO, Colen RR, Abrol S. Radiomic Phenotyping in Brain Cancer to Unravel Hidden Information in Medical Images. Top Magn Reson Imaging. 2017 Feb; 26(1):43-53. PMID: 28079714.
      Citations: 11     Fields:    Translation:Humans
    66. Hassan I, Zinn PO, Colen RR, Elshafeey N. From K-space to Nucleotide: Insights Into the Radiogenomics of Brain Tumors. Top Magn Reson Imaging. 2017 Feb; 26(1):33-41. PMID: 28079715.
      Citations: 1     Fields:    Translation:Humans
    67. Eleneen Y, Colen RR. Cancer Imaging in Immunotherapy. Adv Exp Med Biol. 2017; 995:141-153. PMID: 28321816.
      Citations: 6     Fields:    Translation:HumansAnimals
    68. Singh SK, Mosley JC, Hatami M, Gumin J, Sulman EP, Lang FF, Stueber F, Zinn PO, Colen RR, Luedi MM. A Dexamethasone-regulated Gene Signature Is Prognostic for Poor Survival in Glioblastoma Patients. J Neurosurg Anesthesiol. 2017 Jan; 29(1):46-58. PMID: 27653222; PMCID: PMC5143186.
      Citations: 15     Fields:    Translation:HumansAnimalsCells
    69. Kanas VG, Thomas GA, Zinn PO, Megalooikonomou V, Colen RR, Zacharaki EI. Learning MRI-based classification models for MGMT methylation status prediction in glioblastoma. Comput Methods Programs Biomed. 2017 Mar; 140:249-257. PMID: 28254081.
      Citations: 25     Fields:    Translation:HumansCells
    70. Kotrotsou A, Zinn PO, Colen RR. Radiomics in Brain Tumors: An Emerging Technique for Characterization of Tumor Environment. Magn Reson Imaging Clin N Am. 2016 Nov; 24(4):719-729. PMID: 27742112.
      Citations: 28     Fields:    Translation:Humans
    71. Anil R, Colen RR. Imaging Genomics in Glioblastoma Multiforme: A Predictive Tool for Patients Prognosis, Survival, and Outcome. Magn Reson Imaging Clin N Am. 2016 Nov; 24(4):731-740. PMID: 27742113.
      Citations: 4     Fields:    Translation:Humans
    72. Colen RR, Hassan I, Elshafeey N, Zinn PO. Shedding Light on the 2016 World Health Organization Classification of Tumors of the Central Nervous System in the Era of Radiomics and Radiogenomics. Magn Reson Imaging Clin N Am. 2016 Nov; 24(4):741-749. PMID: 27742114.
      Citations: 5     Fields:    Translation:Humans
    73. Naing A, Papadopoulos KP, Autio KA, Ott PA, Patel MR, Wong DJ, Falchook GS, Pant S, Whiteside M, Rasco DR, Mumm JB, Chan IH, Bendell JC, Bauer TM, Colen RR, Hong DS, Van Vlasselaer P, Tannir NM, Oft M, Infante JR. Safety, Antitumor Activity, and Immune Activation of Pegylated Recombinant Human Interleukin-10 (AM0010) in Patients With Advanced Solid Tumors. J Clin Oncol. 2016 10 10; 34(29):3562-3569. PMID: 27528724; PMCID: PMC5657013.
      Citations: 72     Fields:    Translation:HumansCTClinical Trials
    74. Colen RR. New State-of-the-Art and Cutting-Edge Advances in Brain Tumor Imaging. Magn Reson Imaging Clin N Am. 2016 Nov; 24(4):xv-xvi. PMID: 27742120.
      Citations:    Fields:    Translation:Humans
    75. Zinn PO, Hatami M, Youssef E, Thomas GA, Luedi MM, Singh SK, Colen RR. Diffusion Weighted Magnetic Resonance Imaging Radiophenotypes and Associated Molecular Pathways in Glioblastoma. Neurosurgery. 2016 08; 63 Suppl 1:127-135. PMID: 27399377.
      Citations: 3     Fields:    Translation:HumansCells
    76. Dunn WD, Aerts HJWL, Cooper LA, Holder CA, Hwang SN, Jaffe CC, Brat DJ, Jain R, Flanders AE, Zinn PO, Colen RR, Gutman DA. Assessing the Effects of Software Platforms on Volumetric Segmentation of Glioblastoma. J Neuroimaging Psychiatry Neurol. 2016; 1(2):64-72. PMID: 29600296; PMCID: PMC5870135.
      Citations: 2     
    77. Weathers SP, Han X, Liu DD, Conrad CA, Gilbert MR, Loghin ME, O'Brien BJ, Penas-Prado M, Puduvalli VK, Tremont-Lukats I, Colen RR, Yung WKA, de Groot JF. A randomized phase II trial of standard dose bevacizumab versus low dose bevacizumab plus lomustine (CCNU) in adults with recurrent glioblastoma. J Neurooncol. 2016 09; 129(3):487-494. PMID: 27406589; PMCID: PMC5021605.
      Citations: 28     Fields:    Translation:HumansCTClinical Trials
    78. Andreou C, Neuschmelting V, Tschaharganeh DF, Huang CH, Oseledchyk A, Iacono P, Karabeber H, Colen RR, Mannelli L, Lowe SW, Kircher MF. Imaging of Liver Tumors Using Surface-Enhanced Raman Scattering Nanoparticles. ACS Nano. 2016 05 24; 10(5):5015-26. PMID: 27078225; PMCID: PMC4884645.
      Citations: 39     Fields:    Translation:Animals
    79. Hassan I, Kotrotsou A, Bakhtiari AS, Thomas GA, Weinberg JS, Kumar AJ, Sawaya R, Luedi MM, Zinn PO, Colen RR. Radiomic Texture Analysis Mapping Predicts Areas of True Functional MRI Activity. Sci Rep. 2016 05 06; 6:25295. PMID: 27151623; PMCID: PMC4858648.
      Citations: 11     Fields:    Translation:Humans
    80. Gabrusiewicz K, Rodriguez B, Wei J, Hashimoto Y, Healy LM, Maiti SN, Thomas G, Zhou S, Wang Q, Elakkad A, Liebelt BD, Yaghi NK, Ezhilarasan R, Huang N, Weinberg JS, Prabhu SS, Rao G, Sawaya R, Langford LA, Bruner JM, Fuller GN, Bar-Or A, Li W, Colen RR, Curran MA, Bhat KP, Antel JP, Cooper LJ, Sulman EP, Heimberger AB. Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype. JCI Insight. 2016; 1(2). PMID: 26973881; PMCID: PMC4784261.
      Citations: 194     Fields:    
    81. Messer JA, Mohamed AS, Hutcheson KA, Ding Y, Lewin JS, Wang J, Lai SY, Frank SJ, Garden AS, Sandulache V, Eichelberger H, French CC, Colen RR, Phan J, Kalpathy-Cramer J, Hazle JD, Rosenthal DI, Gunn GB, Fuller CD. Magnetic resonance imaging of swallowing-related structures in nasopharyngeal carcinoma patients receiving IMRT: Longitudinal dose-response characterization of quantitative signal kinetics. Radiother Oncol. 2016 Feb; 118(2):315-22. PMID: 26830697; PMCID: PMC4794348.
      Citations: 14     Fields:    Translation:HumansPHPublic Health
    82. Sathyan P, Zinn PO, Marisetty AL, Liu B, Kamal MM, Singh SK, Bady P, Lu L, Wani KM, Veo BL, Gumin J, Kassem DH, Robinson F, Weng C, Baladandayuthapani V, Suki D, Colman H, Bhat KP, Sulman EP, Aldape K, Colen RR, Verhaak RG, Lu Z, Fuller GN, Huang S, Lang FF, Sawaya R, Hegi M, Majumder S. Mir-21-Sox2 Axis Delineates Glioblastoma Subtypes with Prognostic Impact. J Neurosci. 2015 Nov 11; 35(45):15097-112. PMID: 26558781; PMCID: PMC4642241.
      Citations: 32     Fields:    Translation:HumansAnimalsCells
    83. Rao A, Rao G, Gutman DA, Flanders AE, Hwang SN, Rubin DL, Colen RR, Zinn PO, Jain R, Wintermark M, Kirby JS, Jaffe CC, Freymann J, TCGA Glioma Phenotype Research Group. A combinatorial radiographic phenotype may stratify patient survival and be associated with invasion and proliferation characteristics in glioblastoma. J Neurosurg. 2016 Apr; 124(4):1008-17. PMID: 26473782; PMCID: PMC4990448.
      Citations: 24     Fields:    Translation:Humans
    84. Ding Y, Hazle JD, Mohamed AS, Frank SJ, Hobbs BP, Colen RR, Gunn GB, Wang J, Kalpathy-Cramer J, Garden AS, Lai SY, Rosenthal DI, Fuller CD. Intravoxel incoherent motion imaging kinetics during chemoradiotherapy for human papillomavirus-associated squamous cell carcinoma of the oropharynx: preliminary results from a prospective pilot study. NMR Biomed. 2015 Dec; 28(12):1645-54. PMID: 26451969; PMCID: PMC4715635.
      Citations: 22     Fields:    Translation:Cells
    85. Wangaryattawanich P, Hatami M, Wang J, Thomas G, Flanders A, Kirby J, Wintermark M, Huang ES, Bakhtiari AS, Luedi MM, Hashmi SS, Rubin DL, Chen JY, Hwang SN, Freymann J, Holder CA, Zinn PO, Colen RR. Multicenter imaging outcomes study of The Cancer Genome Atlas glioblastoma patient cohort: imaging predictors of overall and progression-free survival. Neuro Oncol. 2015 Nov; 17(11):1525-37. PMID: 26203066; PMCID: PMC4648306.
      Citations: 42     Fields:    Translation:Humans
    86. Cancer Genome Atlas Research Network, Brat DJ, Verhaak RG, Aldape KD, Yung WK, Salama SR, Cooper LA, Rheinbay E, Miller CR, Vitucci M, Morozova O, Robertson AG, Noushmehr H, Laird PW, Cherniack AD, Akbani R, Huse JT, Ciriello G, Poisson LM, Barnholtz-Sloan JS, Berger MS, Brennan C, Colen RR, Colman H, Flanders AE, Giannini C, Grifford M, Iavarone A, Jain R, Joseph I, Kim J, Kasaian K, Mikkelsen T, Murray BA, O'Neill BP, Pachter L, Parsons DW, Sougnez C, Sulman EP, Vandenberg SR, Van Meir EG, von Deimling A, Zhang H, Crain D, Lau K, Mallery D, Morris S, Paulauskis J, Penny R, Shelton T, Sherman M, Yena P, Black A, Bowen J, Dicostanzo K, Gastier-Foster J, Leraas KM, Lichtenberg TM, Pierson CR, Ramirez NC, Taylor C, Weaver S, Wise L, Zmuda E, Davidsen T, Demchok JA, Eley G, Ferguson ML, Hutter CM, Mills Shaw KR, Ozenberger BA, Sheth M, Sofia HJ, Tarnuzzer R, Wang Z, Yang L, Zenklusen JC, Ayala B, Baboud J, Chudamani S, Jensen MA, Liu J, Pihl T, Raman R, Wan Y, Wu Y, Ally A, Auman JT, Balasundaram M, Balu S, Baylin SB, Beroukhim R, Bootwalla MS, Bowlby R, Bristow CA, Brooks D, Butterfield Y, Carlsen R, Carter S, Chin L, Chu A, Chuah E, Cibulskis K, Clarke A, Coetzee SG, Dhalla N, Fennell T, Fisher S, Gabriel S, Getz G, Gibbs R, Guin R, Hadjipanayis A, Hayes DN, Hinoue T, Hoadley K, Holt RA, Hoyle AP, Jefferys SR, Jones S, Jones CD, Kucherlapati R, Lai PH, Lander E, Lee S, Lichtenstein L, Ma Y, Maglinte DT, Mahadeshwar HS, Marra MA, Mayo M, Meng S, Meyerson ML, Mieczkowski PA, Moore RA, Mose LE, Mungall AJ, Pantazi A, Parfenov M, Park PJ, Parker JS, Perou CM, Protopopov A, Ren X, Roach J, Schein J, Schumacher SE, Seidman JG, Seth S, Shen H, Simons JV, Sipahimalani P, Soloway MG, Song X, Sun H, Tabak B, Tam A, Tan D, Tang J, Thiessen N, Triche T, Van Den Berg DJ, Veluvolu U, Waring S, Weisenberger DJ, Wilkerson MD, Wong T, Wu J, Xi L, Xu AW, Yang L, Zack TI, Zhang J, Aksoy BA, Arachchi H, Benz C, Bernard B, Carlin D, Cho J, DiCara D, Frazer S, Fuller GN, Gao J, Gehlenborg N, Haussler D, Heiman DI, Iype L, Jacobsen A, Ju Z, Katzman S, Kim H, Knijnenburg T, Kreisberg RB, Lawrence MS, Lee W, Leinonen K, Lin P, Ling S, Liu W, Liu Y, Liu Y, Lu Y, Mills G, Ng S, Noble MS, Paull E, Rao A, Reynolds S, Saksena G, Sanborn Z, Sander C, Schultz N, Senbabaoglu Y, Shen R, Shmulevich I, Sinha R, Stuart J, Sumer SO, Sun Y, Tasman N, Taylor BS, Voet D, Weinhold N, Weinstein JN, Yang D, Yoshihara K, Zheng S, Zhang W, Zou L, Abel T, Sadeghi S, Cohen ML, Eschbacher J, Hattab EM, Raghunathan A, Schniederjan MJ, Aziz D, Barnett G, Barrett W, Bigner DD, Boice L, Brewer C, Calatozzolo C, Campos B, Carlotti CG, Chan TA, Cuppini L, Curley E, Cuzzubbo S, Devine K, DiMeco F, Duell R, Elder JB, Fehrenbach A, Finocchiaro G, Friedman W, Fulop J, Gardner J, Hermes B, Herold-Mende C, Jungk C, Kendler A, Lehman NL, Lipp E, Liu O, Mandt R, McGraw M, Mclendon R, McPherson C, Neder L, Nguyen P, Noss A, Nunziata R, Ostrom QT, Palmer C, Perin A, Pollo B, Potapov A, Potapova O, Rathmell WK, Rotin D, Scarpace L, Schilero C, Senecal K, Shimmel K, Shurkhay V, Sifri S, Singh R, Sloan AE, Smolenski K, Staugaitis SM, Steele R, Thorne L, Tirapelli DP, Unterberg A, Vallurupalli M, Wang Y, Warnick R, Williams F, et al. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015 Jun 25; 372(26):2481-98. PMID: 26061751; PMCID: PMC4530011.
      Citations: 1192     Fields:    Translation:HumansCells
    87. Elbanan M, Zinn PO, Colen RR, Moton S. Imaging Genomics of Glioblastoma: Biology, Biomarkers, and Breakthroughs. Top Magn Reson Imaging. 2015 Jun; 24(3):155-63. PMID: 26049819.
      Citations: 7     Fields:    Translation:Humans
    88. Mahmood Z, Elbanan MG, Colen RR, Zinn PO. Imaging Genomics in Gliomas. Cancer J. 2015 May-Jun; 21(3):225-34. PMID: 26049703.
      Citations: 9     Fields:    Translation:Humans
    89. Pemmaraju N, Sasaki K, Johnson D, Daver N, Afshar-Kharghan V, Chen M, Ahmed S, Colen RR, Kwon M, Huh Y, Borthakur G. Successful Treatment of Intracranial Hemorrhage with Recombinant Activated Factor VII in a Patient with Newly Diagnosed Acute Myeloid Leukemia: A Case Report and Review of the Literature. Front Oncol. 2015; 5:29. PMID: 25717439; PMCID: PMC4324079.
      Citations: 1     
    90. ElBanan MG, Amer AM, Zinn PO, Colen RR. Imaging genomics of Glioblastoma: state of the art bridge between genomics and neuroradiology. Neuroimaging Clin N Am. 2015 Feb; 25(1):141-53. PMID: 25476518.
      Citations: 18     Fields:    Translation:Humans
    91. Zinn PO, Singh SK, Colen RR. Shedding light on glioblastoma cellular heterogeneity. Neuro Oncol. 2015 Mar; 17(3):327-8. PMID: 25556242; PMCID: PMC4483105.
      Citations: 2     Fields:    Translation:HumansAnimals
    92. Ding Y, Mohamed AS, Yang J, Colen RR, Frank SJ, Wang J, Wassal EY, Wang W, Kantor ME, Balter PA, Rosenthal DI, Lai SY, Hazle JD, Fuller CD. Prospective observer and software-based assessment of magnetic resonance imaging quality in head and neck cancer: Should standard positioning and immobilization be required for radiation therapy applications? Pract Radiat Oncol. 2015 Jul-Aug; 5(4):e299-308. PMID: 25544553; PMCID: PMC4470880.
      Citations: 21     Fields:    Translation:Humans
    93. Colen RR, Wang J, Singh SK, Gutman DA, Zinn PO. Glioblastoma: imaging genomic mapping reveals sex-specific oncogenic associations of cell death. Radiology. 2015 Apr; 275(1):215-27. PMID: 25490189.
      Citations: 31     Fields:    Translation:Humans
    94. Tang C, Fuller CD, Garden AS, Awan MJ, Colen RR, Morrison WH, Frank SJ, Beadle BM, Phan J, Sturgis EM, Zafereo ME, Weber RS, Rosenthal DI, Gunn GB. Characteristics and kinetics of cervical lymph node regression after radiation therapy for human papillomavirus-associated oropharyngeal carcinoma: quantitative image analysis of post-radiotherapy response. Oral Oncol. 2015 Feb; 51(2):195-201. PMID: 25444304; PMCID: PMC4502963.
      Citations: 5     Fields:    Translation:HumansCells
    95. Mohamed AS, Ruangskul MN, Awan MJ, Baron CA, Kalpathy-Cramer J, Castillo R, Castillo E, Guerrero TM, Kocak-Uzel E, Yang J, Court LE, Kantor ME, Gunn GB, Colen RR, Frank SJ, Garden AS, Rosenthal DI, Fuller CD. Quality assurance assessment of diagnostic and radiation therapy-simulation CT image registration for head and neck radiation therapy: anatomic region of interest-based comparison of rigid and deformable algorithms. Radiology. 2015 Mar; 274(3):752-63. PMID: 25380454; PMCID: PMC4358813.
      Citations: 31     Fields:    Translation:Humans
    96. Rao P, Colen RR, Bruner JM, Meis JM. Extraskeletal myxoid chondrosarcoma presenting as an intradural spinal mass: report of a rare clinical presentation with an emphasis on differential diagnostic considerations. Rare Tumors. 2014 Oct 27; 6(4):5586. PMID: 25568751; PMCID: PMC4274445.
      Citations: 3     
    97. Colen R, Foster I, Gatenby R, Giger ME, Gillies R, Gutman D, Heller M, Jain R, Madabhushi A, Madhavan S, Napel S, Rao A, Saltz J, Tatum J, Verhaak R, Whitman G. NCI Workshop Report: Clinical and Computational Requirements for Correlating Imaging Phenotypes with Genomics Signatures. Transl Oncol. 2014 Oct; 7(5):556-69. PMID: 25389451; PMCID: PMC4225695.
      Citations: 40     
    98. Nicolasjilwan M, Hu Y, Yan C, Meerzaman D, Holder CA, Gutman D, Jain R, Colen R, Rubin DL, Zinn PO, Hwang SN, Raghavan P, Hammoud DA, Scarpace LM, Mikkelsen T, Chen J, Gevaert O, Buetow K, Freymann J, Kirby J, Flanders AE, Wintermark M, TCGA Glioma Phenotype Research Group. Addition of MR imaging features and genetic biomarkers strengthens glioblastoma survival prediction in TCGA patients. J Neuroradiol. 2015 Jul; 42(4):212-21. PMID: 24997477; PMCID: PMC5511631.
      Citations: 53     Fields:    Translation:Humans
    99. Colen RR, Vangel M, Wang J, Gutman DA, Hwang SN, Wintermark M, Jain R, Jilwan-Nicolas M, Chen JY, Raghavan P, Holder CA, Rubin D, Huang E, Kirby J, Freymann J, Jaffe CC, Flanders A, TCGA Glioma Phenotype Research Group, Zinn PO. Imaging genomic mapping of an invasive MRI phenotype predicts patient outcome and metabolic dysfunction: a TCGA glioma phenotype research group project. BMC Med Genomics. 2014 Jun 02; 7:30. PMID: 24889866; PMCID: PMC4057583.
      Citations: 35     Fields:    Translation:HumansCells
    100. Hamilton J, Colen R, Schellingerhout D, Vu T, Rao G, McAleer MF, Mahajan A, Ahmed S. Change in postsurgical cavity size within the first 30 days correlates with extent of surrounding edema: consequences for postoperative radiosurgery. J Comput Assist Tomogr. 2014 May-Jun; 38(3):457-60. PMID: 24681852; PMCID: PMC4181559.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    101. Kocak-Uzel E, Gunn GB, Colen RR, Kantor ME, Mohamed AS, Schoultz-Henley S, Mavroidis P, Frank SJ, Garden AS, Beadle BM, Morrison WH, Phan J, Rosenthal DI, Fuller CD. Beam path toxicity in candidate organs-at-risk: assessment of radiation emetogenesis for patients receiving head and neck intensity modulated radiotherapy. Radiother Oncol. 2014 May; 111(2):281-8. PMID: 24746582; PMCID: PMC4063998.
      Citations: 22     Fields:    Translation:Humans
    102. Jain R, Poisson LM, Gutman D, Scarpace L, Hwang SN, Holder CA, Wintermark M, Rao A, Colen RR, Kirby J, Freymann J, Jaffe CC, Mikkelsen T, Flanders A. Outcome prediction in patients with glioblastoma by using imaging, clinical, and genomic biomarkers: focus on the nonenhancing component of the tumor. Radiology. 2014 Aug; 272(2):484-93. PMID: 24646147; PMCID: PMC4263660.
      Citations: 103     Fields:    Translation:Humans
    103. O'Brien BJ, Colen RR. Post-treatment imaging changes in primary brain tumors. Curr Oncol Rep. 2014; 16(8):397. PMID: 24997979.
      Citations: 13     Fields:    Translation:HumansPHPublic Health
    104. Anderson MD, Colen RR, Tremont-Lukats IW. Imaging mimics of primary malignant tumors of the central nervous system (CNS). Curr Oncol Rep. 2014; 16(8):399. PMID: 24927848.
      Citations: 3     Fields:    Translation:Humans
    105. Zinn PO, Colen RR. Imaging genomic mapping in glioblastoma. Neurosurgery. 2013 Aug; 60 Suppl 1:126-30. PMID: 23839364.
      Citations: 8     Fields:    Translation:Humans
    106. Gutman DA, Cooper LA, Hwang SN, Holder CA, Gao J, Aurora TD, Dunn WD, Scarpace L, Mikkelsen T, Jain R, Wintermark M, Jilwan M, Raghavan P, Huang E, Clifford RJ, Mongkolwat P, Kleper V, Freymann J, Kirby J, Zinn PO, Moreno CS, Jaffe C, Colen R, Rubin DL, Saltz J, Flanders A, Brat DJ. MR imaging predictors of molecular profile and survival: multi-institutional study of the TCGA glioblastoma data set. Radiology. 2013 May; 267(2):560-9. PMID: 23392431; PMCID: PMC3632807.
      Citations: 182     Fields:    Translation:Humans
    107. Zinn PO, Colen RR, Kasper EM, Burkhardt JK. Extent of resection and radiotherapy in GBM: A 1973 to 2007 surveillance, epidemiology and end results analysis of 21,783 patients. Int J Oncol. 2013 Mar; 42(3):929-34. PMID: 23338774.
      Citations: 32     Fields:    Translation:Humans
    108. Jain R, Poisson L, Narang J, Gutman D, Scarpace L, Hwang SN, Holder C, Wintermark M, Colen RR, Kirby J, Freymann J, Brat DJ, Jaffe C, Mikkelsen T. Genomic mapping and survival prediction in glioblastoma: molecular subclassification strengthened by hemodynamic imaging biomarkers. Radiology. 2013 Apr; 267(1):212-20. PMID: 23238158; PMCID: PMC3606543.
      Citations: 68     Fields:    Translation:Humans
    109. Zinn PO, Sathyan P, Mahajan B, Bruyere J, Hegi M, Majumder S, Colen RR. A novel volume-age-KPS (VAK) glioblastoma classification identifies a prognostic cognate microRNA-gene signature. PLoS One. 2012; 7(8):e41522. PMID: 22870228; PMCID: PMC3411674.
      Citations: 45     Fields:    Translation:HumansCells
    110. Danagoulian GS, Qin L, Nayak KS, Colen RR, Mukundan S, Harris MB, Jolesz FA, Shankaranarayanan A, Copen WA, Schmidt EJ. Comparison of wideband steady-state free precession and T2-weighted fast spin echo in spine disorder assessment at 1.5 and 3 T. Magn Reson Med. 2012 Nov; 68(5):1527-35. PMID: 22287191; PMCID: PMC3712341.
      Citations: 2     Fields:    Translation:Humans
    111. Colen RR, Zinn PO, Hazany S, Do-Dai D, Wu JK, Yao K, Zhu JJ. Magnetic resonance imaging appearance and changes on intracavitary Gliadel wafer placement: A pilot study. World J Radiol. 2011 Nov 28; 3(11):266-72. PMID: 22132297; PMCID: PMC3226960.
      Citations: 14     
    112. Zinn PO, Mahajan B, Majadan B, Sathyan P, Singh SK, Majumder S, Jolesz FA, Colen RR. Radiogenomic mapping of edema/cellular invasion MRI-phenotypes in glioblastoma multiforme. PLoS One. 2011; 6(10):e25451. PMID: 21998659; PMCID: PMC3187774.
      Citations: 136     Fields:    Translation:Humans
    113. Egger J, Colen RR, Freisleben B, Nimsky C. Manual refinement system for graph-based segmentation results in the medical domain. J Med Syst. 2012 Oct; 36(5):2829-39. PMID: 21826501; PMCID: PMC3691109.
      Citations: 16     Fields:    
    114. Zinn PO, Colen RR, Kasper EM, Chen CC. Posterior leukoencephalopathy following repair of an ileocecal anastomosis breakdown: a case report and review of the literature. J Med Case Rep. 2011 Jan 19; 5:20. PMID: 21247426; PMCID: PMC3035195.
      Citations: 1     Fields:    
    115. Puri AS, Colen RR, Reddy AS, Groff MW, DiNobile D, Killoran T, Nikolic B, Thomas AJ. Lumbar artery pseudoaneurysm after percutaneous vertebroplasty: a unique vascular complication. J Neurosurg Spine. 2011 Feb; 14(2):296-9. PMID: 21214310.
      Citations: 8     Fields:    Translation:Humans
    116. Colen RR, Kekhia H, Jolesz FA. Multimodality intraoperative MRI for brain tumor surgery. Expert Rev Neurother. 2010 Oct; 10(10):1545-58. PMID: 20945538.
      Citations: 9     Fields:    Translation:Humans
    117. Ghaghada KB, Colen RR, Hawley CR, Patel N, Mukundan S. Liposomal contrast agents in brain tumor imaging. Neuroimaging Clin N Am. 2010 Aug; 20(3):367-78. PMID: 20708552.
      Citations:    Fields:    Translation:Humans
    118. Colen RR, Jolesz FA. Future potential of MRI-guided focused ultrasound brain surgery. Neuroimaging Clin N Am. 2010 Aug; 20(3):355-66. PMID: 20708551.
      Citations: 11     Fields:    Translation:Humans
    119. Burkhardt JK, Zinn PO, Bozinov O, Colen RR, Bertalanffy H, Kasper EM. Neurosurgical education in Europe and the United States of America. Neurosurg Rev. 2010 Oct; 33(4):409-17. PMID: 20429023; PMCID: PMC3683626.
      Citations: 2     Fields:    Translation:Humans
    120. Miller JC, Hirsch JA, Colen RR, Colon RA, Buonanno FS, Thrall JH, Uppot RN. Cerebral aneurysms. J Am Coll Radiol. 2010 Jan; 7(1):73-6. PMID: 20129278; PMCID: PMC3691108.
      Citations: 1     Fields:    Translation:Humans
    121. Roedl JB, Blake MA, Holalkere NS, Mueller PR, Colen RR, Harisinghani MG. Lymph node staging in esophageal adenocarcinoma with PET-CT based on a visual analysis and based on metabolic parameters. Abdom Imaging. 2009 Sep-Oct; 34(5):610-7. PMID: 18830663.
      Citations: 6     Fields:    Translation:Humans
    122. Roedl JB, Prabhakar HB, Mueller PR, Colen RR, Blake MA. Prediction of metastatic disease and survival in patients with gastric and gastroesophageal junction tumors: the incremental value of PET-CT over PET and the clinical role of primary tumor volume measurements. Acad Radiol. 2009 Feb; 16(2):218-26. PMID: 19124108.
      Citations: 3     Fields:    Translation:Humans
    123. Roedl JB, Harisinghani MG, Colen RR, Fischman AJ, Blake MA, Mathisen DJ, Mueller PR. Assessment of treatment response and recurrence in esophageal carcinoma based on tumor length and standardized uptake value on positron emission tomography-computed tomography. Ann Thorac Surg. 2008 Oct; 86(4):1131-8. PMID: 18805147.
      Citations: 13     Fields:    Translation:Humans
    124. Roedl JB, Halpern EF, Colen RR, Sahani DV, Fischman AJ, Blake MA. Metabolic tumor width parameters as determined on PET/CT predict disease-free survival and treatment response in squamous cell carcinoma of the esophagus. Mol Imaging Biol. 2009 Jan-Feb; 11(1):54-60. PMID: 18769974.
      Citations: 24     Fields:    Translation:Humans
    125. Roedl JB, Colen RR, Holalkere NS, Fischman AJ, Choi NC, Blake MA. Adenocarcinomas of the esophagus: response to chemoradiotherapy is associated with decrease of metabolic tumor volume as measured on PET-CT. Comparison to histopathologic and clinical response evaluation. Radiother Oncol. 2008 Dec; 89(3):278-86. PMID: 18701180.
      Citations: 46     Fields:    Translation:Humans
    126. Roedl JB, Colen RR, King K, Fischman AJ, Mueller PR, Blake MA. Visual PET/CT scoring for nonspecific 18F-FDG uptake in the differentiation of early malignant and benign esophageal lesions. AJR Am J Roentgenol. 2008 Aug; 191(2):515-21. PMID: 18647925.
      Citations: 11     Fields:    Translation:Humans
    127. Roedl JB, Sahani DV, Colen RR, Fischman AJ, Mueller PR, Blake MA. Tumour length measured on PET-CT predicts the most appropriate stage-dependent therapeutic approach in oesophageal cancer. Eur Radiol. 2008 Dec; 18(12):2833-40. PMID: 18651155.
      Citations: 10     Fields:    Translation:Humans
    128. Ryan R, Abbara S, Colen RR, Arnous S, Quinn M, Cury RC, Dodd JD. Cardiac valve disease: spectrum of findings on cardiac 64-MDCT. AJR Am J Roentgenol. 2008 May; 190(5):W294-303. PMID: 18430815.
      Citations: 10     Fields:    Translation:Humans
    129. Colen RR, Singer AE, McLoud TC. Cryptococcal pneumonia in an immunocompetent patient. AJR Am J Roentgenol. 2007 Mar; 188(3):W281-2. PMID: 17312037.
      Citations:    Fields:    Translation:Humans
    130. Colen RR, Nagle JA, Wittram C. Radiologic-pathologic conference of the Massachusetts General Hospital. Pulmonary hyalinizing granuloma. AJR Am J Roentgenol. 2007 Jan; 188(1):W15-6. PMID: 17179320.
      Citations: 4     Fields:    Translation:Humans
    131. Ramos JM, Ruiz A, Colen R, Lopez ID, Grossman L, Matta JL. DNA repair and breast carcinoma susceptibility in women. Cancer. 2004 Apr 01; 100(7):1352-7. PMID: 15042667.
      Citations: 46     Fields:    Translation:HumansCells
    132. Radiomic Phenotyping in Brain Cancer to Unravel Hidden Information in Medical Images. Topics in Magnetic Resonance Imaging.
    133. Extraskeletal myxoid chondrosarcoma presenting as an intradural spinal mass. Rare Tumors. 6:150-153.
    134. Prospective observer and software-based assessment of magnetic resonance imaging quality in head and neck cancer. Practical Radiation Oncology.
    135. Statistical feature selection for enhanced detection of brain tumor.
    136. Imaging of Liver Tumors Using Surface-Enhanced Raman Scattering Nanoparticles. ACS Nano. 10:5015-5026.
    137. Safety, antitumor activity, and immune activation of pegylated recombinant human interleukin-10 (AM0010) in patients with advanced solid tumors. Journal of Clinical Oncology. 34:3562-3569.
    138. Multicenter imaging outcomes study of The Cancer Genome Atlas glioblastoma patient cohort. Neuro-Oncology. 17:1525-1537.
    139. A combinatorial radiographic phenotype may stratify patient survival and be associated with invasion and proliferation characteristics in glioblastoma. Journal of Neurosurgery. 124:1008-1017.
    140. Radiomics texture feature extraction for characterizing GBM phenotypes using GLCM. 84-87.
    141. Imaging Genomics in Glioblastoma Multiforme. Magnetic Resonance Imaging Clinics of North America. 24:731-740.
    142. Survival analysis of pre-operative GBM patients by using quantitative image features. 625-627.
    143. Mir-21-Sox2 axis delineates glioblastoma subtypes with prognostic impact. Journal of Neuroscience. 35:15097-15112.
    144. Shedding light on glioblastoma cellular heterogeneity. Neuro-Oncology. 17:327-328.
    145. Shedding Light on the 2016 World Health Organization Classification of Tumors of the Central Nervous System in the Era of Radiomics and Radiogenomics. Magnetic Resonance Imaging Clinics of North America. 24:741-749.
    146. Successful treatment of intracranial hemorrhage with recombinant activated factor VII in a patient with newly diagnosed acute myeloid leukemia. Frontiers in Oncology. 5.
    147. Erratum. Journal of the American College of Radiology. 8:147.
    148. Intravoxel incoherent motion imaging kinetics during chemoradiotherapy for human papillomavirus-associated squamous cell carcinoma of the oropharynx. NMR in Biomedicine.
    149. A randomized phase II trial of standard dose bevacizumab versus low dose bevacizumab plus lomustine (CCNU) in adults with recurrent glioblastoma. Journal of Neuro-Oncology. 1-8.
    150. Brain tumor identification using Gaussian Mixture Model features and Decision Trees classifier.
    151. Learning MRI-based classification models for MGMT methylation status prediction in glioblastoma. Computer Methods and Programs in Biomedicine. 140:249-257.
    152. A Dexamethasone-regulated Gene Signature Is Prognostic for Poor Survival in Glioblastoma Patients. Journal of Neurosurgical Anesthesiology.
    153. Quantitative texture analysis for Glioblastoma phenotypes discrimination. 605-608.
    154. New State-of-the-Art and Cutting-Edge Advances in Brain Tumor Imaging. Magnetic Resonance Imaging Clinics of North America. 24:xv-xvi.
    155. Magnetic resonance imaging of swallowing-related structures in nasopharyngeal carcinoma patients receiving IMRT. Radiotherapy and Oncology. 118:315-322.
    156. Radiomic Texture Analysis Mapping Predicts Areas of True Functional MRI Activity. Scientific Reports. 6.
    157. From K-space to Nucleotide. Topics in Magnetic Resonance Imaging.
    158. NCI workshop report. Translational Oncology. 7:556-569.
    159. Diffusion Weighted Magnetic Resonance Imaging Radiophenotypes and Associated Molecular Pathways in Glioblastoma. Neurosurgery. 63:127-135.
    160. Integrating multi-platform genomic data using hierarchical Bayesian relevance vector machines. 18-21.
    161. Radiomics and Radiogenomics in Breast Cancer. Breast Diseases. 27:23-24.
    162. Addition of MR imaging features and genetic biomarkers strengthens glioblastoma survival prediction in TCGA patients. Journal of Neuroradiology. 42:212-221.
    163. Dynamic contrast-enhanced MRI detects acute radiotherapy-induced alterations in mandibular microvasculature. Scientific Reports. 6.
    164. Congenital and acquired abnormalities of the cardiac valves. Applied Radiology. 36:40-50.
    165. Radiomics in Brain Tumors. Magnetic Resonance Imaging Clinics of North America. 24:719-729.
    COLEN's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (371)
    Explore
    _
    Co-Authors (148)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _